About
Technology
Issues
FAQ
Links
Official Page
15440 Cost-per-responder analysis of guselkumab versus secukinumab in obese patients using efficacy results from the ECLIPSE head-to-head clinical trial
site/software ©
exaly
; All materials licenced under
CC by-SA
.